Clinical Trial Update: A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating 9MW2821 versus physician's choice in recurrent or metastatic cervical cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• 9MW2821

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Cervical Cancer | Phase 3 | Status: RECRUITING